Log in to save to my catalogue

Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percu...

Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2385885876

Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention

About this item

Full title

Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention

Publisher

New York: Springer US

Journal title

Cardiovascular drugs and therapy, 2020-04, Vol.34 (2), p.179-188

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose
To compare the risk of cardiovascular events between patients with two CYP2C19 loss-of-function alleles who were prescribed ticagrelor or clopidogrel after percutaneous coronary intervention (PCI).
Methods
Patients with two loss-of-function alleles based on the CYP2C19 genotype were selected from patients enrolled in a retrospectiv...

Alternative Titles

Full title

Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2385885876

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2385885876

Other Identifiers

ISSN

0920-3206,1573-7241

E-ISSN

1573-7241

DOI

10.1007/s10557-020-06956-4

How to access this item